G

Green Thumb Industries Inc
CNSX:GTII

Watchlist Manager
Green Thumb Industries Inc
CNSX:GTII
Watchlist
Price: 11.52 CAD 4.63% Market Closed
Market Cap: 2.7B CAD
Have any thoughts about
Green Thumb Industries Inc?
Write Note

Green Thumb Industries Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Green Thumb Industries Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
Green Thumb Industries Inc
CNSX:GTII
Cash from Financing Activities
-$92.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$6.4B
CAGR 3-Years
27%
CAGR 5-Years
21%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
$7.7B
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
-$5.7B
CAGR 3-Years
34%
CAGR 5-Years
14%
CAGR 10-Years
8%
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$6.3B
CAGR 3-Years
-72%
CAGR 5-Years
13%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Green Thumb Industries Inc
Glance View

Market Cap
2.7B CAD
Industry
Pharmaceuticals

Green Thumb Industries Inc., a notable player in the U.S. cannabis industry, operates like a well-tuned orchestra, harmonizing various elements of the cannabis business. The Chicago-based company is vertically integrated, meaning it controls each aspect of its product lifecycle—from cultivation to distribution. This structure enables Green Thumb to maintain consistency in its product quality while maximizing its operational efficiency. At the heart of its business model lies a diverse portfolio of well-regarded cannabis brands that cater to different consumer segments, from high-end connoisseurs to medicinal users seeking relief. These brands, including RYTHM, Dogwalkers, and Beboe, are strategically distributed across its extensive network of retail outlets, known as RISE dispensaries, as well as through wholesale channels. Like a savvy trader on a bustling market floor, Green Thumb’s profitability hinges on its ability to enhance scale while navigating the complex regulatory landscape. In each state where it operates, the company must tailor its approach to meet varying levels of regulation and market maturity. This agility provides Green Thumb with a competitive edge, allowing it to efficiently expand in both medical and adult-use markets while adhering to legal standards. The company generates revenue not only from its direct-to-consumer sales through dispensaries but also through wholesale transactions with other cannabis retailers. By maintaining robust relationships across these segments, Green Thumb underscores its position as a cornerstone of the cannabis industry's growth narrative.

GTII Intrinsic Value
22.6 CAD
Undervaluation 49%
Intrinsic Value
Price
G

See Also

What is Green Thumb Industries Inc's Cash from Financing Activities?
Cash from Financing Activities
-92.2m USD

Based on the financial report for Sep 30, 2024, Green Thumb Industries Inc's Cash from Financing Activities amounts to -92.2m USD.

Back to Top